[Pharmacokinetic of glipentide (UR-661) by IV. administration on healthy and diabetic volunteers (author's transl)].
D001549:Benzamides / Q000008:administration & dosage / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D002250:Carbon Radioisotopes; D002986:Clinical Trials as Topic; D003517:Cyclopentanes / Q000008:administration & dosage / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D010179:Pancreas / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*
D001549:Benzamides; D001786:Blood Glucose; D002250:Carbon Radioisotopes; D003517:Cyclopentanes; D013453:Sulfonylurea Compounds
Cinética de la glipentida (UR-661) tras administración I.V. a voluntarios sanos y diabéticos